查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2040394

獸醫精準醫療市場規模、佔有率和趨勢分析報告：按類型、動物、治療領域、客戶、地區和細分市場預測（2026-2033 年）

Veterinary Precision Medicine Market Size, Share & Trends Analysis Report By Type, By Animal, By Therapeutic Area, By Customer, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

獸醫精準醫療市場概覽

全球獸醫精準醫療市場預計到 2025 年將價值 5.589 億美元，預計到 2033 年將達到 15.095 億美元。

預計從 2026 年到 2033 年，該市場將以 13.5% 的複合年成長率成長。成長要素包括伴侶動物癌症盛行率的上升、由於寵物「人性化」而增加的治療投資、透過人工智慧/機器學習提高的生物資訊學能力以及機構對比較腫瘤學的投資湧入。

全球獸醫精準醫療產業涵蓋伴侶動物和生產動物的基因組分析、分子診斷、精準治療指導和生物資訊服務，涉及腫瘤學、感染疾病、免疫學及其他治療領域。目前，商業服務主要集中在犬類腫瘤領域，但在貓和其他物種中的應用正在不斷擴展。人工智慧 (AI) 和機器學習 (ML) 與生物資訊學平台的整合顯著提升了獸醫精準醫療服務的臨床效用。計算模型如今能夠將複雜的多體學和活細胞資料集轉化為個人化、可操作的治療指南——這是以往僅靠傳統基因組分析無法實現的。

例如，ImpriMed的平台可以說是這項變革中最具商業性價值的應用。其「藥物反應預測」服務利用基於龐大且經臨床驗證的資料來源訓練的人工智慧模型，為犬類癌症患者產生個人化的治療預測。該服務分析多達13種常用血液腫瘤治療藥物在患者活細胞中的療效，並在6-7天內提供結果。根據發表在《腫瘤學前沿》（Frontiers in Oncology）雜誌上的一份報告，基於ImpriMed人工智慧預測進行治療的複發性B細胞淋巴瘤犬的中位生存期為160-187天，95%的受訪獸醫腫瘤學家表示對該服務感到滿意。迄今為止，ImpriMed的測試已應用於過去五年中超過3700例犬貓患者，分析了超過10,000個個別檢體。此外，人工智慧的應用範圍已從藥物反應預測擴展到影像領域，機器學習演算法正被訓練用於檢測X光影像和組織病理學資料中的腫瘤相關異常。人工智慧在診斷和生物資訊服務各領域日益成長的效用，正使這項技術不再局限於小眾功能，而是成為市場驅動力。

伴侶動物癌症模型的轉化價值正在加速機構和商業性對獸醫精準醫療基礎設施的投資。伴侶動物的自發性癌症與人類惡性腫瘤共用重要的生物學和分子特徵，跨物種研究已推動了許多進展，例如從犬骨癌研究中衍生出的保肢手術技術，以及透過貓乳腺腫瘤研究加深對人類乳癌中荷爾蒙影響的理解。一項發表於2026年2月的研究，由包括Wellcome-Sanger實驗室、圭爾夫大學和伯恩大學在內的多家機構合作完成，分析了來自五個國家約500個寵物貓腫瘤樣本的癌基因組。該研究由EveryCat健康基金會、CVS集團、Wellcome基金會、加拿大自然科學與工程研究理事會和瑞士國家科學基金會。來自多個資助機構的如此大規模的跨國投資表明，機構層級在比較腫瘤學的優先順序上發生了結構性轉變。

此外，透過廣泛的多中心獸醫臨床實驗室研究來拓展比較腫瘤學研究，被認為是彌合臨床前研究成果與臨床實踐之間差距的關鍵。涵蓋學術機構、獸醫診所、產業夥伴和監管機構的合作網路構成了轉化研究的框架。此類跨組織合作正在直接擴大對獸醫精準醫療服務的需求和資金基礎。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 定價模式分析
  • 以使用者觀點的分析
  • 用例分析
  • 市場分析工具

第4章：獸醫精準醫療市場：按類型分類的估算與趨勢分析

  • 獸醫精準醫療市場：按類型分類的波動分析
  • 獸醫精準醫療市場：按類型分類、估算和預測（2021-2033 年）
  • 基因組分析與定序
  • 診斷與病理學
  • 精準治療
  • 生物資訊學和數據分析

第5章：獸醫精準醫療市場：依動物種類分類的估算與趨勢分析

  • 獸醫精準醫療市場：動物特異性波動分析
  • 獸醫精準醫療市場：按動物種類分類的估算與預測（2021-2033 年）
  • 狗
  • 貓
  • 其他動物

第6章：獸醫精準醫療市場：依治療領域分類的估算與趨勢分析

  • 獸醫精準醫療市場：依治療領域分類的波動分析
  • 獸醫精準醫療市場：依治療領域分類的估算與預測（2021-2033 年）
  • 腫瘤學
  • 感染疾病
  • 免疫學與自體免疫疾病
  • 肌肉骨骼疾病
  • 其他治療領域

第7章：獸醫精準醫療市場：依客戶群分類的估算與趨勢分析

  • 獸醫精準醫療市場：以客戶為基礎的波動分析
  • 獸醫精準醫療市場：按客戶分類、估算和預測（2021-2033 年）
  • 獸醫醫院和診所
  • 獸醫學術和研究機構
  • 獸醫診斷實驗室
  • 其他顧客

第8章：獸醫精準醫療市場：區域估算與趨勢分析

  • 區域市場概覽
  • 2025年及2033年區域市佔率分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 科威特
    • 卡達
    • 阿曼

第9章 競爭情勢

  • 參與企業的分類
    • 市場領導
    • 新興企業
  • 2025年市佔率及估值分析（熱圖分析）
  • 公司簡介
    • Zoetis
    • Idexx Laboratories
    • ImpriMed
    • FidoCure（One Health Company）
    • Anivive Lifesciences（Vidium Animal Health）
    • VetOmics Animal Health
    • LEAH Labs
    • Elias Animal Health
    • testblu diagnostics GmbH
    • PetDx
    • Torigen, Inc
    • Oxford BioDynamics
Product Code: GVR-4-68040-900-6

Veterinary Precision Medicine Market Summary

The global veterinary precision medicine market size was estimated at USD 558.9 million in 2025 and is projected to reach USD 1,509.5 million by 2033, growing at a CAGR of 13.5% from 2026 to 2033. The market is growing due to factors such as rising companion animal cancer prevalence, pet humanization boosting treatment investment, AI/ML advancing bioinformatics capabilities, and comparative oncology attracting institutional investment.

The global veterinary precision medicine industry encompasses genomic profiling, molecular diagnostics, precision therapy guidance, and bioinformatics services delivered across companion and production animals, spanning oncology, infectious diseases, immunology, and other therapeutic areas. Commercial service adoption is currently primarily in canine oncology, with expanding applications in feline and other species. The integration of artificial intelligence and machine learning into bioinformatics platforms has significantly elevated the clinical utility of veterinary precision medicine services. Computational models are now capable of converting complex multi-omics and live-cell datasets into individualized, actionable treatment guidance; a capability that was not achievable through conventional genomic analysis alone.

For instance, ImpriMed's platform represents the most commercially validated application of this shift. Its Drug Response Predictions service uses AI models trained on extensive, clinically proven data sources to generate personalized treatment predictions for canine cancer patients, analyzing the efficacy of up to 13 commonly prescribed blood cancer drugs on patients' living cells, with results delivered within 6 to 7 days. Dogs with relapsed B-cell lymphoma treated under ImpriMed's AI-guided predictions recorded a median survival time of 160 to 187 days, as published in Frontiers in Oncology, and 95% of surveyed veterinary oncologists reported satisfaction with the service. To date, ImpriMed's tests have been applied to over 3,700 canine and feline patients over five years, with over 10,000 individual samples analyzed. Furthermore, AI applications are expanding beyond drug response prediction into imaging diagnostics, where machine learning algorithms are being trained to detect tumor-associated abnormalities in radiographic and histopathological data. This broadening of AI utility across the diagnostic and bioinformatics service stack positions the technology as a structural market driver rather than a niche capability.

The translational value of companion animal cancer models is accelerating institutional and commercial investment in veterinary precision medicine infrastructure. Naturally occurring cancers in companion animals share key biological and molecular characteristics with human malignancies, with cross-species insights already informing advances such as limb-sparing surgical techniques derived from canine osteosarcoma research and improved understanding of hormonal influences in human breast cancer through feline mammary tumor studies. A study published in February 2026, conducted across institutions including the Wellcome Sanger Institute, the University of Guelph, and the University of Bern, mapped the oncogenome of the domestic cat across nearly 500 tumor samples sourced from five countries. The study was funded by the EveryCat Health Foundation, CVS Group, Wellcome, the Natural Sciences and Engineering Research Council of Canada, and the Swiss National Science Foundation. This scale of multi-national, multi-funder investment signals a structural shift in how comparative oncology is being prioritized at the institutional level.

In addition, expanding comparative oncology research through broad, multicenter veterinary clinical trials is identified as essential for bridging gaps between preclinical findings and clinical practice, with collaborative networks spanning academic institutions, veterinary practices, industry partners, and regulatory bodies forming translational research frameworks. This institutional convergence is directly expanding the demand and funding base for veterinary precision medicine services.

Global Veterinary Precision Medicine Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the veterinary precision medicine market report based on type, animal, therapeutic area, customer, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Genomic Profiling & Sequencing
  • Diagnostic & Pathology
  • Precision Therapy & Treatment
  • Bioinformatics & Data Analytics
  • Animal Outlook (Revenue, USD Million, 2021 - 2033)
  • Dogs
  • Cats
  • Other Animals
  • Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Infectious Diseases
  • Immunology & Autoimmune Disorders
  • Musculoskeletal Disorders
  • Other Therapeutic Areas
  • Customer Outlook (Revenue, USD Million, 2021 - 2033)
  • Veterinary Hospitals & Clinics
  • Veterinary Academic & Research Institutions
  • Veterinary Diagnostic Laboratories
  • Other Customers
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Oman
    • Qatar

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Animal
    • 1.2.3. Therapeutic Area
    • 1.2.4. Customers
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information/Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Model 1: Commodity Flow Analysis
    • 1.7.2. Model 2: Bottom-Up Analysis
    • 1.7.3. Model 3: Volume-Pricing Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary/Related Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Companion Animal Cancer Prevalence
      • 3.2.1.2. Pet Humanization Boosting Treatment Investment
      • 3.2.1.3. AI/ML Advancing Bioinformatics Capabilities
      • 3.2.1.4. Comparative Oncology Attracting Institutional Investment
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Costs Limiting Clinical Adoption
      • 3.2.2.2. Limited Validated Multi-Species Assays
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Pricing Model Analysis
  • 3.4. User Perspective Analysis
  • 3.5. Case Study Analysis
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTEL by SWOT Analysis

Chapter 4. Veterinary Precision Medicine Market: By Type Estimates & Trend Analysis

  • 4.1. Veterinary Precision Medicine Market, By Type: Segment Dashboard
  • 4.2. Veterinary Precision Medicine Market, By Type: Movement Analysis
  • 4.3. Veterinary Precision Medicine Market Estimates & Forecasts, by Type, 2021 to 2033 (USD Million)
  • 4.4. Genomic Profiling & Sequencing
    • 4.4.1. Genomic Profiling & Sequencing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Diagnostic & Pathology
    • 4.5.1. Diagnostic & Pathology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Precision Therapy & Treatment
    • 4.6.1. Precision Therapy & Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Bioinformatics & Data Analytics
    • 4.7.1. Bioinformatics & Data Analytics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Veterinary Precision Medicine Market: By Animal Estimates & Trend Analysis

  • 5.1. Veterinary Precision Medicine Market, By Animal: Segment Dashboard
  • 5.2. Veterinary Precision Medicine Market, By Animal Movement Analysis
  • 5.3. Veterinary Precision Medicine Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million)
  • 5.4. Dogs
    • 5.4.1. Dogs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Cats
    • 5.5.1. Cats Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Other Animals
    • 5.6.1. Other Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Veterinary Precision Medicine Market: By Therapeutic Area Estimates & Trend Analysis

  • 6.1. Veterinary Precision Medicine Market, By Therapeutic Area: Segment Dashboard
  • 6.2. Veterinary Precision Medicine Market, By Therapeutic Area Movement Analysis
  • 6.3. Veterinary Precision Medicine Market Estimates & Forecasts, by Therapeutic Area, 2021 to 2033 (USD Million)
  • 6.4. Oncology
    • 6.4.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Infectious Diseases
    • 6.5.1. Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Immunology & Autoimmune Disorders
    • 6.6.1. Immunology & Autoimmune Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Musculoskeletal Disorders
    • 6.7.1. Musculoskeletal Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Other Therapeutic Areas
    • 6.8.1. Other Therapeutic Areas Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Veterinary Precision Medicine Market: By Customer Estimates & Trend Analysis

  • 7.1. Veterinary Precision Medicine Market, By Customer: Segment Dashboard
  • 7.2. Veterinary Precision Medicine Market, By Customer Movement Analysis
  • 7.3. Veterinary Precision Medicine Market Estimates & Forecasts, by Customer, 2021 to 2033 (USD Million)
  • 7.4. Veterinary Hospitals & Clinics
    • 7.4.1. Veterinary Hospitals & Clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Veterinary Academic & Research Institutions
    • 7.5.1. Veterinary Academic & Research Institutions Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Veterinary Diagnostic Laboratories
    • 7.6.1. Veterinary Diagnostic Laboratories Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Other Customers
    • 7.7.1. Other Customers Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Veterinary Precision Medicine Market: By Regional Estimates & Trend Analysis

  • 8.1. Region Market Dashboard
  • 8.2. Region Market Share Analysis, 2025 & 2033
  • 8.3. North America
    • 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. South Korea
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. Saudi Arabia
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.6. Qatar
      • 8.7.6.1. Key Country Dynamics
      • 8.7.6.2. Competitive Scenario
      • 8.7.6.3. Regulatory Framework
      • 8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.7. Oman
      • 8.7.7.1. Key Country Dynamics
      • 8.7.7.2. Competitive Scenario
      • 8.7.7.3. Regulatory Framework
      • 8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
    • 9.1.1. Market Leaders
    • 9.1.2. Emerging Players
  • 9.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
  • 9.3. Company Profiles
    • 9.3.1. Zoetis
      • 9.3.1.1. Participant's Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product/Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Idexx Laboratories
      • 9.3.2.1. Participant's Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product/Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. ImpriMed
      • 9.3.3.1. Participant's Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product/Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. FidoCure (One Health Company)
      • 9.3.4.1. Participant's Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product/Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Anivive Lifesciences (Vidium Animal Health)
      • 9.3.5.1. Participant's Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product/Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. VetOmics Animal Health
      • 9.3.6.1. Participant's Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product/Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. LEAH Labs
      • 9.3.7.1. Participant's Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product/Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Elias Animal Health
      • 9.3.8.1. Participant's Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product/Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. testblu diagnostics GmbH
      • 9.3.9.1. Participant's Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product/Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. PetDx
      • 9.3.10.1. Participant's Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product/Service Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Torigen, Inc
      • 9.3.11.1. Participant's Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Product/Service Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. Oxford BioDynamics
      • 9.3.12.1. Participant's Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Product/Service Benchmarking
      • 9.3.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 4 Global Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 5 Global Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 6 Global Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 7 North America Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 8 North America Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 9 North America Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 10 North America Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 11 U.S. Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 12 U.S. Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 13 U.S. Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 14 U.S. Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 15 Canada Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 16 Canada Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 17 Canada Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 18 Canada Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 19 Mexico Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 20 Mexico Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 21 Mexico Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 22 Mexico Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 23 Europe Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 24 Europe Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 25 Europe Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 26 Europe Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 27 UK Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 28 UK Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 29 UK Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 30 UK Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 31 Germany Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 32 Germany Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 33 Germany Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 34 Germany Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 35 France Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 36 France Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 37 France Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 38 France Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 39 Italy Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 40 Italy Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 41 Italy Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 42 Italy Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 43 Spain Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 44 Spain Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 45 Spain Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 46 Spain Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 47 Denmark Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 48 Denmark Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 49 Denmark Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 50 Denmark Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 51 Sweden Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 52 Sweden Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 53 Sweden Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 54 Sweden Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 55 Norway Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 56 Norway Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 57 Norway Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 58 Norway Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 59 Asia Pacific Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 60 Asia Pacific Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 63 Japan Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 64 Japan Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 65 Japan Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 66 Japan Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 67 China Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 68 China Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 69 China Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 70 China Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 71 India Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 72 India Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 73 India Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 74 India Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 75 Australia Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 76 Australia Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 77 Australia Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 78 Australia Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 79 South Korea Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 80 South Korea Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 81 South Korea Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 82 South Korea Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 83 Thailand Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 84 Thailand Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 85 Thailand Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 86 Thailand Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 87 Latin America Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 88 Latin America Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 89 Latin America Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 90 Latin America Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 91 Brazil Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 92 Brazil Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 93 Brazil Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 94 Brazil Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 95 Argentina Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 96 Argentina Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 97 Argentina Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 98 Argentina Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 99 Middle East & Africa (MEA) Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 100 Middle East & Africa (MEA) Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 101 Middle East & Africa (MEA) Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 102 Middle East & Africa (MEA) Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 103 South Africa Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 104 South Africa Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 105 South Africa Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 106 South Africa Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 107 Saudi Arabia Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 108 Saudi Arabia Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 109 Saudi Arabia Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 110 Saudi Arabia Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 111 UAE Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 112 UAE Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 113 UAE Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 114 UAE Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 115 Kuwait Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 116 Kuwait Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 117 Kuwait Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 118 Kuwait Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 119 Oman Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 120 Oman Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 121 Oman Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 122 Oman Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)
  • Table 123 Qatar Veterinary Precision Medicine Market, By Type, 2021 - 2033 (USD Million)
  • Table 124 Qatar Veterinary Precision Medicine Market, By Animal, 2021 - 2033 (USD Million)
  • Table 125 Qatar Veterinary Precision Medicine Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 126 Qatar Veterinary Precision Medicine Market, By Customer, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Veterinary Precision Medicine Market, Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Veterinary Precision Medicine Market, for Type, 2021 - 2033 (USD Million)
  • Fig. 15 Global Veterinary Precision Medicine Market, for Genomic Profiling & Sequencing, 2021 - 2033 (USD Million)
  • Fig. 16 Global Veterinary Precision Medicine Market, for Diagnostic & Pathology, 2021 - 2033 (USD Million)
  • Fig. 17 Global Veterinary Precision Medicine Market, for Precision Therapy & Treatment, 2021 - 2033 (USD Million)
  • Fig. 18 Global Veterinary Precision Medicine Market, for Bioinformatics & Data Analytics, 2021 - 2033 (USD Million)
  • Fig. 19 Global Veterinary Precision Medicine Market, for Animal, 2021 - 2033 (USD Million)
  • Fig. 20 Global Veterinary Precision Medicine Market, for Dogs, 2021 - 2033 (USD Million)
  • Fig. 21 Global Veterinary Precision Medicine Market, for Cats, 2021 - 2033 (USD Million)
  • Fig. 22 Global Veterinary Precision Medicine Market, for Other Animals, 2021 - 2033 (USD Million)
  • Fig. 23 Global Veterinary Precision Medicine Market, for Therapeutic Area, 2021 - 2033 (USD Million)
  • Fig. 24 Global Veterinary Precision Medicine Market, for Oncology, 2021 - 2033 (USD Million)
  • Fig. 25 Global Veterinary Precision Medicine Market, for Infectious Diseases, 2021 - 2033 (USD Million)
  • Fig. 26 Global Veterinary Precision Medicine Market, for Immunology & Autoimmune Disorders, 2021 - 2033 (USD Million)
  • Fig. 27 Global Veterinary Precision Medicine Market, for Musculoskeletal Disorders, 2021 - 2033 (USD Million)
  • Fig. 28 Global Veterinary Precision Medicine Market, for Other Therapeutic Areas, 2021 - 2033 (USD Million)
  • Fig. 29 Global Veterinary Precision Medicine Market, for Customers, 2021 - 2033 (USD Million)
  • Fig. 30 Global Veterinary Precision Medicine Market, for Veterinary Hospitals & Clinics, 2021 - 2033 (USD Million)
  • Fig. 31 Global Veterinary Precision Medicine Market, for Veterinary Academic & Research Institutions, 2021 - 2033 (USD Million)
  • Fig. 32 Global Veterinary Precision Medicine Market, for Veterinary Diagnostic Laboratories, 2021 - 2033 (USD Million)
  • Fig. 33 Global Veterinary Precision Medicine Market, for Other Customers, 2021 - 2033 (USD Million)
  • Fig. 34 Regional Outlook, 2025 & 2033
  • Fig. 35 North America Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 36 Key Country Dynamics
  • Fig. 37 U.S. Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 38 Key Country Dynamics
  • Fig. 39 Canada Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 40 Key Country Dynamics
  • Fig. 41 Mexico Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 42 Europe Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 43 Key Country Dynamics
  • Fig. 44 UK Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 45 Key Country Dynamics
  • Fig. 46 Germany Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 47 Key Country Dynamics
  • Fig. 48 France Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 49 Key Country Dynamics
  • Fig. 50 Italy Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 51 Key Country Dynamics
  • Fig. 52 Spain Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 53 Key Country Dynamics
  • Fig. 54 Denmark Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 55 Key Country Dynamics
  • Fig. 56 Sweden Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 57 Key Country Dynamics
  • Fig. 58 Norway Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 59 Asia Pacific Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 60 Key Country Dynamics
  • Fig. 61 Japan Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 62 Key Country Dynamics
  • Fig. 63 China Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 64 Key Country Dynamics
  • Fig. 65 India Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 66 Key Country Dynamics
  • Fig. 67 Australia Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 68 Key Country Dynamics
  • Fig. 69 South Korea Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 70 Key Country Dynamics
  • Fig. 71 Thailand Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 72 North America
  • Fig. 73 Key Country Dynamics
  • Fig. 74 Brazil Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 75 Key Country Dynamics
  • Fig. 76 Argentina Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 77 Middle East & Africa (MEA)Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 78 Key Country Dynamics
  • Fig. 79 South Africa Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 80 Key Country Dynamics
  • Fig. 81 Saudi Arabia Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 82 Key Country Dynamics
  • Fig. 83 UAE Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 84 Key Country Dynamics
  • Fig. 85 Kuwait Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 86 Key Country Dynamics
  • Fig. 87 Oman Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)
  • Fig. 88 Key Country Dynamics
  • Fig. 89 Qatar Veterinary Precision Medicine Market, 2021 - 2033 (USD Million)